PortfoliosLab logoPortfoliosLab logo
MOAT.L vs. DRDR.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MOAT.L vs. DRDR.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Morningstar US Sustainable Wide Moat UCITS ETF (MOAT.L) and iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

MOAT.L is traded in USD, while DRDR.L is traded in GBp. To make them comparable, the DRDR.L values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, MOAT.L achieves a -3.50% return, which is significantly lower than DRDR.L's -0.86% return.


MOAT.L

1D
-0.86%
1M
1.39%
YTD
-3.50%
6M
-3.97%
1Y
6.98%
3Y*
7.81%
5Y*
3.00%
10Y*
10.50%

DRDR.L

1D
-1.61%
1M
2.48%
YTD
-0.86%
6M
-1.65%
1Y
17.76%
3Y*
5.34%
5Y*
-2.27%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MOAT.L vs. DRDR.L - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MOAT.L
VanEck Morningstar US Sustainable Wide Moat UCITS ETF
-3.50%7.34%11.12%18.37%-18.70%25.53%13.62%33.78%-1.64%22.51%
DRDR.L
iShares Healthcare Innovation UCITS ETF USD (Acc)
-0.86%18.57%0.91%2.63%-24.02%-6.07%53.25%13.25%-3.66%35.46%

Correlation

The correlation between MOAT.L and DRDR.L is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.71

Correlation (3Y)
Calculated over the trailing 3-year period

0.71

Correlation (5Y)
Calculated over the trailing 5-year period

0.71

Correlation (All Time)
Calculated using the full available price history since Sep 9, 2016

0.67

The correlation between MOAT.L and DRDR.L has been stable across timeframes, ranging from 0.67 to 0.71 - a consistent structural relationship.

MOAT.L vs. DRDR.L - Sectors Allocation Comparison


Sectors
MOAT.L
DRDR.L

Technology

24.3%
1.2%

Healthcare

23.2%
98.0%

Consumer Defensive

18.1%
0.1%

Industrials

8.8%
0.4%

Consumer Cyclical

7.4%

-

Financial Services

7.4%
0.2%

Communication Services

6.2%

-

Basic Materials

4.2%
0.4%

Real Estate

0.5%

-

Energy

-

-

Utilities

-

-

Technology

MOAT.L
24.3%
DRDR.L
1.2%

Healthcare

MOAT.L
23.2%
DRDR.L
98.0%

Consumer Defensive

MOAT.L
18.1%
DRDR.L
0.1%

Industrials

MOAT.L
8.8%
DRDR.L
0.4%

Consumer Cyclical

MOAT.L
7.4%
DRDR.L

-

Financial Services

MOAT.L
7.4%
DRDR.L
0.2%

Communication Services

MOAT.L
6.2%
DRDR.L

-

Basic Materials

MOAT.L
4.2%
DRDR.L
0.4%

Real Estate

MOAT.L
0.5%
DRDR.L

-

Energy

MOAT.L

-

DRDR.L

-

Utilities

MOAT.L

-

DRDR.L

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MOAT.L vs. DRDR.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MOAT.L
MOAT.L Risk / Return Rank: 1818
Overall Rank
MOAT.L Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
MOAT.L Sortino Ratio Rank: 1919
Sortino Ratio Rank
MOAT.L Omega Ratio Rank: 1717
Omega Ratio Rank
MOAT.L Calmar Ratio Rank: 1717
Calmar Ratio Rank
MOAT.L Martin Ratio Rank: 1717
Martin Ratio Rank

DRDR.L
DRDR.L Risk / Return Rank: 3737
Overall Rank
DRDR.L Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
DRDR.L Sortino Ratio Rank: 4343
Sortino Ratio Rank
DRDR.L Omega Ratio Rank: 3838
Omega Ratio Rank
DRDR.L Calmar Ratio Rank: 3636
Calmar Ratio Rank
DRDR.L Martin Ratio Rank: 3030
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MOAT.L vs. DRDR.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Morningstar US Sustainable Wide Moat UCITS ETF (MOAT.L) and iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MOAT.LDRDR.LDifference
Sharpe ratioReturn per unit of total volatility

-0.56

Sortino ratioReturn per unit of downside risk

-0.78

Omega ratioGain probability vs. loss probability

1.10

1.19

-0.10

Calmar ratioReturn relative to maximum drawdown

0.62

1.41

-0.80

Martin ratioReturn relative to average drawdown

1.65

3.46

-1.81

MOAT.L vs. DRDR.L - Sharpe Ratio Comparison

The current MOAT.L Sharpe Ratio is 0.53, which is lower than the DRDR.L Sharpe Ratio of 1.09. The chart below compares the historical Sharpe Ratios of MOAT.L and DRDR.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MOAT.LDRDR.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.53

1.09

-0.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.18

-0.10

+0.28

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.62

Sharpe Ratio (All Time)

Calculated using the full available price history

0.66

0.13

+0.54

Drawdowns

MOAT.L vs. DRDR.L - Drawdown Comparison

The maximum MOAT.L drawdown since its inception was -32.78%, smaller than the maximum DRDR.L drawdown of -46.15%. Use the drawdown chart below to compare losses from any high point for MOAT.L and DRDR.L.


Loading charts...

Drawdown Indicators


MOAT.LDRDR.LDifference

Max Drawdown

Largest peak-to-trough decline

-32.78%

-46.15%

+13.37%

Max Drawdown (1Y)

Largest decline over 1 year

-11.86%

-12.93%

+1.07%

Max Drawdown (3Y)

Largest decline over 3 years

-21.84%

-21.31%

-0.53%

Max Drawdown (5Y)

Largest decline over 5 years

-27.06%

-43.52%

+16.46%

Max Drawdown (10Y)

Largest decline over 10 years

-32.78%

Current Drawdown

Current decline from peak

-5.84%

-21.03%

+15.19%

Average Drawdown

Average peak-to-trough decline

-5.56%

-21.04%

+15.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.44%

5.29%

-0.85%

Volatility

MOAT.L vs. DRDR.L - Volatility Comparison

The current volatility for VanEck Morningstar US Sustainable Wide Moat UCITS ETF (MOAT.L) is 3.60%, while iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) has a volatility of 5.20%. This indicates that MOAT.L experiences smaller price fluctuations and is considered to be less risky than DRDR.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MOAT.LDRDR.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.60%

5.20%

-1.60%

Volatility (6M)

Calculated over the trailing 6-month period

9.65%

12.66%

-3.01%

Volatility (1Y)

Calculated over the trailing 1-year period

13.79%

16.78%

-2.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.32%

23.57%

-7.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.91%

23.49%

-6.58%

MOAT.L vs. DRDR.L - Expense Ratio Comparison

MOAT.L has a 0.49% expense ratio, which is higher than DRDR.L's 0.40% expense ratio.


Dividends

MOAT.L vs. DRDR.L - Dividend Comparison

Neither MOAT.L nor DRDR.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


MOAT.L and DRDR.L have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, DRDR.L is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.

DRDR.L is cheaper with a 0.40% expense ratio, compared with 0.49% for MOAT.L.

MOAT.L is categorized as Large Cap Blend Equities, while DRDR.L is Health & Biotech Equities. MOAT.L tracks Russell 1000 TR USD, while DRDR.L tracks MSCI World/Health Care NR USD. They also come from different issuers: VanEck and iShares. Their fees differ too: 0.49% for MOAT.L and 0.40% for DRDR.L.

Portfolio Optimizer

Find the right allocation for MOAT.L and DRDR.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer